Digital twin technology allows for a digital replica to be created of something in the real world, then manipulated and tested virtually. For example, if a healthcare provider has a patient with a heart condition, they could input the patient’s data into the program, run tests, and develop a treatment plan, all without having to touch the patient.

The Center for Behavioral Neuroscience at Georgia State University is transforming our understanding of the brain through groundbreaking research while inspiring the next generation of scientists. Explore the center's 25 years of pioneering collaboration, discovery, and impact

Fasting has shown its potential to reduce colorectal cancer risk by triggering cellular changes that may slow tumor growth, with a study demonstrating a 20% improvement in overall survival. However, since cancer is also influenced by genetic factors, lifestyle changes alone aren't enough for prevention.Non-invasive tests like BGI Genomics' COLOTECT®, based on next-generation sequencing (NGS) technology, help detect early signs of colorectal cancer before symptoms appear.

Parkinson's disease can impact people at any age. Genetic testing offers a way to identify genetic markers early, enabling timely intervention and better management of the disease.

Jennifer Dahne, Ph.D., received the South Carolina Governor’s Young Scientist Award for Excellence in Scientific Research. This award, jointly awarded by the governor’s office and the South Carolina Academy of Science, honors a “gifted young researcher” who has the “potential for major contributions to his or her discipline.”

Substandard and fake medicines remain a major threat in Africa, risking lives and fuelling drug resistance. A unified regulatory system, like the African Medicines Agency, backed by leadership training programmes like ARLP, could strengthen oversight, boost self-reliance, and save lives.

Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now officially recognized as a distinct form of the disease, known as type 5 diabetes. The new designation, made today by the International Diabetes Federation (IDF), stems largely from the research and advocacy of Meredith Hawkins, M.D., M.S., professor of medicine, the Harold and Muriel Block Chair in Medicine, and founding director of the Global Diabetes Institute at Albert Einstein College of Medicine.

Universidad Carlos III de Madrid (UC3M) has launched two new business incubation and acceleration programmes, CR3A and CONSOLIDA, to promote the creation and consolidation of businesses that seek to offer products and services based on technologies and knowledge developed at the university.